Parameter
| Biomarker | 13-mRNA signature (incl. CTHRC1, MMP11) | Full name | 13-mRNA signature (incl. Collagen Triple Helix Repeat Containing 1, Matrix Metallopeptidase 11) | Molecular Type | Nucleic acid (mRNA) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis & progression prediction |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue (RNA-seq, qRT-PCR) | ||
| Pathobiological Mechanisms | LASSO-derived signature stratifies high-/low-risk groups; CTHRC1 up-regulated in invasive BC | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Outperforms previously published signatures; awaits prospective validation | ||||